Problem statement: Answer the multiple-choice question.
Query: Which drug has a -0.341\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1cccc(NC(=S)NC2CCCC2)c1
b.) CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
Answer: b. CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
CCC(C)(C)NC(=O)c1cc(C(=O)OC)cc([N+](=O)[O-])c1
methyl 3-(2-methylbutan-2-ylcarbamoyl)-5-nitrobenzoate